This is a medication change that requires medical supervision, and here is how to have that conversation productively
Injection site rashes associated with semaglutide can result from several distinct mechanisms
The increased risk may relate to rapid weight loss, changes in gallbladder motility, or alterations in bile acid composition
Less food going in means less waste coming out
The medication may trigger headaches indirectly by lowering blood sugar levels, dehydration, or vascular changes
Conversely, studies have shown that both patients and healthcare professionals are reluctant to initiate GLP-1RAs [11, 12], despite the guideline recommendations and the health benefits of these therapies, particularly for patients in need of weight loss and those with low estimated glomerular filtration rate [1]